Hepatitis B SIG Poster Highlights
Nov
09
2025
Convention Center: Science in the Park - Site A - Level 3
3:45 PM
- 4:15 PM
World Class Speakers
Description
Join us for a poster highlight of the top abstracts from the Hepatitis B/Delta (HBV/HDV) SIG.Journey Maps
Presentations
3:45 PM
- 3:48 PM
Jun
24
2026
Convention Center - Science in the Park - Site A - Level 3
Welcome & Introductions
Robert Gish, MD
, Moderator
Hepatitis
3:48 PM
- 3:53 PM
Jun
24
2026
Convention Center - Science in the Park - Site A - Level 3
Preclinical pharmacology and safety of CRMA-1001, a novel epigenetic editor for chronic hepatitis B that demonstrates HBV surface antigen loss in animal models via precise HBV DNA methylation
Sarah Voytek, PhD
, Presenter
Hepatitis
3:53 PM
- 3:58 PM
Jun
24
2026
Convention Center - Science in the Park - Site A - Level 3
A novel mRNA-based immunotherapy achieves complete elimination of human hepatitis B virus in chronic HBV mouse models
Gongxin He, PhD
, Presenter
Hepatitis
3:58 PM
- 4:03 PM
Jun
24
2026
Convention Center - Science in the Park - Site A - Level 3
Hepatitis B Surface Antigen Level Identifies Inactive Chronic Hepatitis B Patients with HCC Risk Below Surveillance Threshold
Tai-Chung Tseng, PhD
, Presenter
Hepatitis
4:03 PM
- 4:15 PM
Jun
24
2026
Convention Center - Science in the Park - Site A - Level 3
Q&A/Panel Discussion/Closing
Scott K. Fung, MD, FRCPC, FAASLD
, Moderator
Hepatitis